| |
| |
|
| Insider
Information: |
Wasman Jane |
| Relationship: |
Director |
| City: |
Hawthorne |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
237,961 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$165,783 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
237,961 |
|
|
| Total
Value |
$165,783 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Acorda Therapeutics Inc |
ACOR |
President, Intl and GC |
2019-12-02 |
117,420 |
|
0 |
Premium* |
|
|
Rigel Pharmaceuticals Inc |
RIGL |
|
2023-05-26 |
75,000 |
2021-05-19 |
0 |
Premium* |
|
|
SELLAS Life Sciences Group Inc |
SLS |
Director |
2024-01-22 |
10,400 |
2022-01-31 |
0 |
Premium* |
|
|
Athersys Inc (New) |
ATHX |
Director |
2023-01-09 |
35,141 |
2022-09-16 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SLS |
SELLAS Life Sciences Grou... |
Director |
– • – |
2024-01-22 |
4 |
A |
$0.00 |
$0 |
D/D |
6,000 |
10,400 |
0 |
- |
|
| RIGL |
Rigel Pharmaceuticals Inc |
|
• • – |
2023-05-26 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
75,000 |
0 |
- |
|
| SLS |
SELLAS Life Sciences Grou... |
Director |
– • – |
2023-02-02 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
4,400 |
0 |
- |
|
| ATHX |
Athersys Inc (New) |
Director |
– • – |
2023-01-09 |
4 |
A |
$0.00 |
$0 |
D/D |
22,321 |
35,141 |
0 |
- |
|
| ATHX |
Athersys Inc (New) |
Director |
– • – |
2022-09-16 |
4 |
A |
$0.00 |
$0 |
D/D |
12,820 |
12,820 |
0 |
- |
|
| RIGL |
Rigel Pharmaceuticals Inc |
|
• • – |
2022-05-20 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
50,000 |
0 |
- |
|
| SLS |
SELLAS Life Sciences Grou... |
Director |
– • – |
2022-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
1,900 |
1,900 |
0 |
- |
|
| RIGL |
Rigel Pharmaceuticals Inc |
Director |
– • – |
2021-05-19 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
25,000 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
President, Intl and GC |
• – – |
2019-12-02 |
4 |
AS |
$1.60 |
$3,553 |
D/D |
(2,227) |
117,420 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
President, Intl and GC |
• – – |
2019-03-08 |
4 |
A |
$0.00 |
$0 |
D/D |
12,813 |
119,647 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
President, Intl and GC |
• – – |
2019-02-21 |
4 |
D |
$13.38 |
$12,751 |
D/D |
(953) |
106,834 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
President, Intl and GC |
• – – |
2018-12-22 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
107,787 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
President, Intl and GC |
• – – |
2018-12-03 |
4 |
AS |
$20.52 |
$62,947 |
D/D |
(3,067) |
105,287 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
President, Intl and GC |
• – – |
2018-11-05 |
4 |
D |
$20.28 |
$19,367 |
D/D |
(955) |
108,354 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
President, Intl and GC |
• – – |
2018-09-10 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
109,309 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
President, Intl and GC |
• – – |
2018-03-08 |
4 |
D |
$25.65 |
$63,356 |
D/D |
(2,470) |
106,809 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
President, Intl and GC |
• – – |
2018-03-05 |
4 |
D |
$25.95 |
$59,010 |
D/D |
(2,274) |
109,279 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
President, Intl and GC |
• – – |
2018-03-05 |
4 |
OE |
$19.81 |
$59,034 |
D/D |
2,980 |
111,553 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
President, Intl and GC |
• – – |
2018-02-22 |
4 |
A |
$0.00 |
$0 |
D/D |
6,463 |
108,573 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
President, Intl and GC |
• – – |
2018-01-19 |
4 |
AS |
$27.58 |
$952,319 |
D/D |
(34,520) |
102,110 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
President, Intl and GC |
• – – |
2018-01-19 |
4 |
OE |
$19.81 |
$683,841 |
D/D |
34,520 |
136,630 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
President, Intl and GC |
• – – |
2017-12-01 |
4 |
AS |
$20.52 |
$93,662 |
D/D |
(4,564) |
102,110 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
President, Intl and GC |
• – – |
2017-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
106,674 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
President, Intl and GC |
• – – |
2017-02-09 |
4 |
AS |
$22.30 |
$1,216,218 |
D/D |
(54,536) |
101,674 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
President, Intl and GC |
• – – |
2017-02-09 |
4 |
OE |
$22.13 |
$1,206,882 |
D/D |
54,536 |
156,210 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
